Rising global awareness of mental health conditions has significantly reshaped healthcare priorities in recent years. Improved diagnostic capabilities and expanding access to psychiatric care are influencing treatment adoption patterns worldwide. The Panic Disorder Market is experiencing steady expansion due to increasing demand for effective therapeutic interventions and supportive care solutions. According to Expert Market Research, evolving clinical approaches and broader access to mental health services are shaping treatment pathways.

Rising prevalence of panic attacks and comorbid psychiatric disorders has strengthened global healthcare focus on early diagnosis and intervention. Detailed insights are available in the report published by Expert Market Research, highlighting therapeutic innovations and evolving demand patterns. Healthcare providers and pharmaceutical companies are increasingly collaborating to enhance patient-centered care models. This shift reflects growing recognition of mental health as a critical component of overall wellbeing.

Advancements in pharmacological treatments and cognitive behavioral therapy are reshaping care delivery models worldwide. The Panic Disorder Market benefits from rising adoption of SSRIs, SNRIs, and benzodiazepines in structured treatment plans. Expert Market Research highlights that improved healthcare infrastructure in developed economies is supporting early intervention strategies. In addition, increasing patient awareness campaigns are reducing stigma and encouraging timely treatment-seeking behavior.

Explore the Report – Free Sample with Detailed TOC Available

Regional healthcare policies and insurance coverage expansions are playing a significant role in shaping treatment accessibility. Expert Market Research notes that continuous innovation in psychiatric medications is enhancing long-term management outcomes. Digital health platforms and telepsychiatry services are also improving reach in underserved areas. These combined factors are expected to sustain steady growth momentum across global markets.

Market Overview

Panic disorder is a psychiatric condition characterized by recurrent and unexpected panic attacks accompanied by intense fear and physical symptoms such as palpitations, sweating, and dizziness. The Panic Disorder Market is closely linked with growing mental health awareness and expanding therapeutic innovations in both pharmacological and non-pharmacological domains. Expert Market Research emphasizes that increasing diagnosis rates and reduced stigma around mental health are driving demand. Additionally, healthcare systems are increasingly integrating mental health into primary care frameworks, supporting broader treatment adoption and improved patient outcomes across global populations.

Market Size & Forecast

As per Expert Market Research, the Panic Disorder Market was valued at USD 10.11 USD in 2025. The market is projected to expand steadily at a CAGR of 4.18% during the forecast period 2026–2035, supported by rising treatment adoption and expanding mental healthcare infrastructure. By 2035, the market is anticipated to reach a forecast value of USD 15.23 Billion, reflecting sustained demand for advanced therapies and improved access to psychiatric care services across developed and emerging economies.

Macroeconomic & Industry Linkage Analysis

Macroeconomic factors such as rising healthcare expenditure, insurance penetration, and government mental health initiatives are strongly influencing the Panic Disorder Market. Economic stability in developed regions has enabled greater investment in psychiatric research and drug development. Expert Market Research highlights that public health programs aimed at mental wellness are further accelerating diagnosis and treatment adoption globally.

Additionally, increasing urbanization and workplace stress levels are contributing to higher incidences of anxiety-related disorders. Pharmaceutical companies are responding with enhanced R&D investments in targeted therapies. Expert Market Research observes that favorable reimbursement frameworks and digital healthcare adoption are reinforcing market expansion across both developed and emerging regions.

Key Growth Drivers

• Rising prevalence of anxiety and panic-related disorders globally.
• Increasing adoption of pharmacological treatments such as SSRIs, SNRIs, and benzodiazepines.
• Growing integration of cognitive behavioral therapy in treatment protocols.
• Expansion of mental health awareness campaigns reducing stigma.
• Advancements in telepsychiatry and digital mental health platforms.

Market Trends

One of the major trends shaping the Panic Disorder Market is the increasing shift toward combination therapy approaches that integrate medication with psychotherapy. Expert Market Research notes that cognitive behavioral therapy is gaining prominence due to its long-term effectiveness in managing panic symptoms. Pharmaceutical innovation is also contributing to more targeted and better-tolerated drug formulations.

Another emerging trend is the rising adoption of telemedicine and digital mental health platforms. These technologies are improving access to psychiatric care, particularly in remote and underserved regions. Expert Market Research indicates that digital therapeutics and mobile-based mental health applications are becoming integral to modern treatment ecosystems.

Market Challenges & Risk Factors

Despite steady growth, the Panic Disorder Market faces challenges such as underdiagnosis and social stigma associated with mental health conditions. Many patients still delay treatment due to lack of awareness or cultural barriers. Expert Market Research highlights that disparities in healthcare access continue to limit treatment penetration in low-income regions.

Another key challenge is the side-effect profile associated with certain pharmacological treatments. Long-term dependency risks and variability in patient response can hinder treatment adherence. Additionally, regulatory hurdles and lengthy drug approval processes may slow down the introduction of innovative therapies in the market.

Market Opportunities

The increasing adoption of digital health solutions presents significant opportunities in the Panic Disorder Market. Mobile health applications and virtual therapy platforms are expanding access to mental healthcare services. Expert Market Research emphasizes that these technologies are particularly valuable in addressing treatment gaps in rural and underserved populations.

Furthermore, ongoing pharmaceutical research into novel antidepressants and anxiolytics is expected to unlock new growth avenues. Collaboration between biotech firms and healthcare institutions is accelerating innovation in personalized mental health treatment. These advancements are likely to strengthen long-term market expansion.

Value Chain & Supply Chain Analysis

The value chain of the Panic Disorder Market involves multiple stages, including raw material sourcing, drug development, clinical trials, regulatory approvals, and distribution through healthcare providers and pharmacies. Expert Market Research notes that pharmaceutical companies play a central role in driving innovation and ensuring treatment availability. Efficient supply chain management is essential for maintaining consistent drug availability across global markets. Collaboration between manufacturers, distributors, and healthcare institutions ensures streamlined delivery of therapies to patients in need.

Market Segmentation Analysis

The Panic Disorder Market is segmented based on type into Agoraphobia, Social Anxiety Disorder (SAD), Obsessive-Compulsive Disorder (OCD), Bipolar Disorder, Post-Traumatic Stress Disorder (PTSD), Specific Phobias, Generalized Anxiety Disorder (GAD), Major Depressive Disorder (MDD), and Others. By therapy, it includes Electroconvulsive Therapy (ECT) and Cognitive-Behavioral Therapy (CBT). Based on drug class, the market includes Benzodiazepines (BZD), Serotonin-Norepinephrine Reuptake Inhibitors (SNRI), Monoamine Oxidase Inhibitors (MAOIs), Anti-Depressants, Tricyclic Antidepressants (TCAs), Pregabalin, Buspirone, Sertraline, and Others. By route of administration, it is segmented into Oral and Parenteral forms. Regionally, the market spans the United States, United Kingdom, Germany, France, Italy, Spain, and Japan.

Competitive Landscape

The competitive landscape of the Panic Disorder Market is characterized by the presence of leading pharmaceutical companies focusing on innovation, strategic collaborations, and expanding mental health portfolios. Expert Market Research highlights that companies are increasingly investing in R&D to develop safer and more effective psychiatric medications.

Key companies include:

• Teva Pharmaceutical Industries Ltd
• Sun Pharmaceutical Industries Ltd.
• Mylan
• AstraZeneca
• Abbott
• Baxter
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline plc
• Recordati S.p.A.
• Boehringer Ingelheim International GmbH.
• Neurocrine Biosciences, Inc
• Sanofi

Frequently Asked Questions

1. Current market size: The Panic Disorder Market was valued at USD 10.11 USD in 2025.

2. Projected CAGR: The market is expected to grow at a CAGR of 4.18% from 2026 to 2035.

3. Leading region: Developed markets such as the United States and Europe dominate due to advanced healthcare infrastructure.

4. Key companies: Major players include Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd., and AstraZeneca among others.

5. Growth drivers: Rising prevalence of anxiety disorders, therapy adoption, and digital mental health expansion.

6. Market segments: Type, therapy, drug class, route of administration, and region.

7. Challenges: Stigma, underdiagnosis, and treatment side effects.

8. Forecast value by 2035: The market is projected to reach USD 15.23 Billion by 2035.

”

About Us:

Expert Market Research is a leading market intelligence and consulting platform delivering data-driven insights across commodities, chemicals, energy, and industrial markets. Our research helps businesses, analysts, investors, and procurement teams understand price trends, supply-demand dynamics, competitive landscapes, benchmark best practices, and develop long-term market strategies.

Our robust research methodologies, combined with validated primary and secondary data, ensure accuracy, consistency, and relevance. Our analysis is widely used not only for strategic planning, market-entry assessments, and sourcing decisions, but also for investment evaluation across international markets. Our strong emphasis on transparency, factual reporting, and regular data updates to reflect real-time market conditions always keeps you ahead of the curve.

Media Contact:

Company Name: Expert Market Research
Email: sales@expertmarketresearch.com
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: C-130 Sector 2 Noida, Uttar Pradesh 201301
Website: https://www.expertmarketresearch.com